Last reviewed · How we verify

Melatonin Patches

Ain Shams University · FDA-approved active Small molecule

Melatonin binds to melatonin receptors (MT1 and MT2) to regulate circadian rhythm and promote sleep.

Melatonin binds to melatonin receptors (MT1 and MT2) to regulate circadian rhythm and promote sleep. Used for Insomnia and sleep disorders, Circadian rhythm disorders.

At a glance

Generic nameMelatonin Patches
Also known asMelatonin Stickers
SponsorAin Shams University
Drug classMelatonin receptor agonist
TargetMT1 and MT2 melatonin receptors
ModalitySmall molecule
Therapeutic areaNeurology / Sleep Medicine
PhaseFDA-approved

Mechanism of action

Melatonin is an endogenous hormone that acts as a chronobiotic agent, synchronizing the body's internal clock with the external light-dark cycle. By activating melatonin receptors in the suprachiasmatic nucleus and other tissues, it facilitates sleep onset and maintains sleep-wake cycle homeostasis. The transdermal patch formulation provides sustained delivery to maintain therapeutic melatonin levels throughout the night.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: